Biological
JS015
JS015 is a biological therapy with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_2
1
25%
Ph phase_1
3
75%
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Other(1)
Detailed Status
Recruiting2
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 13 (75.0%)
Phase 21 (25.0%)
Trials by Status
unknown125%
recruiting250%
not_yet_recruiting125%
Recent Activity
2 active trials
Showing 4 of 4
recruitingphase_2
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
NCT06885385
recruitingphase_1
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
NCT06139211
not_yet_recruitingphase_1
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
NCT06370754
unknownphase_1
A Phase I Study Of JS015 in Patients With Advanced Solid Tumors
NCT05770310
Clinical Trials (4)
Showing 4 of 4 trials
NCT06885385Phase 2
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
NCT06139211Phase 1
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
NCT06370754Phase 1
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
NCT05770310Phase 1
A Phase I Study Of JS015 in Patients With Advanced Solid Tumors
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4